Gupta Sanjaya K, Ya'qoub Lina, Wimmer Alan P, Fisher Stanley, Saeed Ibrahim M
Departments of Cardiology (S.K.G., A.P.W., I.M.S.) and Neurology (S.F.), Saint Luke's Mid-America Heart Institute, 4401 Wornall Rd, Kansas City, MO 64111; University of Missouri-Kansas City, Kansas City, Mo (S.K.G., A.P.W., S.F., I.M.S.); Department of Cardiology, Ochsner-Louisiana State University, Shreveport, La (L.Y.); and Saint Luke's Marion Bloch Neuroscience Institute, Kansas City, Mo (S.F.).
Radiol Cardiothorac Imaging. 2020 Oct 22;2(5):e200086. doi: 10.1148/ryct.2020200086. eCollection 2020 Oct.
To explore the safety and clinical utility of MRI in participants with non-MRI-conditional cardiac implantable electronic devices, by establishing the Patient Registry of Magnetic Resonance Imaging in Non-Approved DEvices (PROMeNADe).
From September 2015 to June 2019, 532 participants (211 women) with a mean age of 69 years ± 14 (standard deviation) were enrolled prospectively in the PROMeNADe registry (ClinicalTrials.gov identifier: NCT03081364) and underwent a total of 608 MRI examinations (61 cardiac MRI examinations). All participants had device interrogations performed before and after each MRI. Pacemaker-dependent patients received asynchronous pacing. Patients with an implantable cardioverter defibrillator (ICD) had tachycardia therapies disabled during the MRI. An electrophysiology nurse monitored participants for any hemodynamic or rhythm abnormalities. Referring physicians were surveyed regarding the clinical utility of the MRI. Standard descriptive analyses included summary statistics with percentages and means.
Cardiac devices included pacemakers (46%), ICDs (30%), cardiac resynchronization therapy (CRT) pacemakers (4%), and CRT defibrillators (17%), as well as abandoned leads (2%). Pacemaker-dependent patients comprised 27% of all MRI examinations. There were no patient- or device-related complications. Clinical utility surveys of MRI examinations were completed by 150 physicians. According to the survey responses, these MRI examinations changed the suspected diagnosis 25% of the time and changed suspected prognosis in 26% of participants, with planned medical or surgical treatment being changed 42% of the time.
This registry demonstrates that MRI examinations, including thoracic MRI examinations, can be performed safely in patients who have non-MRI-conditional devices, in pacemaker-dependent patients with ICDs, and in patients with abandoned leads. These MRI examinations can have a substantial impact on patient care, justifying the extensive resources used to perform them.© RSNA, 2020See also the commentary by Peshock in this issue.
通过建立非批准设备磁共振成像患者登记系统(PROMeNADe),探讨磁共振成像(MRI)在非MRI条件适用的心脏植入式电子设备患者中的安全性和临床应用价值。
2015年9月至2019年6月,532名参与者(211名女性)前瞻性纳入PROMeNADe登记系统(ClinicalTrials.gov标识符:NCT03081364),共接受608次MRI检查(61次心脏MRI检查)。所有参与者在每次MRI检查前后均进行了设备问询。起搏器依赖患者接受非同步起搏。植入式心律转复除颤器(ICD)患者在MRI检查期间禁用心动过速治疗。一名电生理护士监测参与者有无任何血流动力学或节律异常。就MRI的临床应用价值对转诊医生进行了调查。标准描述性分析包括百分比和均值的汇总统计。
心脏设备包括起搏器(46%)、ICD(30%)、心脏再同步治疗(CRT)起搏器(4%)、CRT除颤器(17%)以及废弃导线(2%)。起搏器依赖患者占所有MRI检查的27%。未发生与患者或设备相关的并发症。150名医生完成了MRI检查的临床应用价值调查。根据调查反馈,这些MRI检查在25%的情况下改变了疑似诊断,在26%的参与者中改变了疑似预后,在42%的情况下改变了计划中的医疗或手术治疗。
该登记系统表明,MRI检查,包括胸部MRI检查,可在非MRI条件适用设备的患者、有ICD的起搏器依赖患者以及有废弃导线的患者中安全进行。这些MRI检查可对患者护理产生重大影响,证明进行这些检查所使用的大量资源是合理的。©RSNA,2020另见本期Peshock的评论。